0000925741-19-000002.txt : 20190107 0000925741-19-000002.hdr.sgml : 20190107 20190107152153 ACCESSION NUMBER: 0000925741-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190107 DATE AS OF CHANGE: 20190107 EFFECTIVENESS DATE: 20190107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-329834 FILM NUMBER: 19513190 BUSINESS ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 D 1 primary_doc.xml X0708 D LIVE 0000925741 BioCardia, Inc. 125 SHOREWAY ROAD SUITE B SAN CARLOS CA CALIFORNIA 94070 650-226-0123 DELAWARE Tiger X Medical, Inc. Cardo Medical, Inc. CLICKNSETTLE COM INC Corporation true Peter Altman 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Executive Officer Director Simon Stertzer 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Director Thomas Quertermous 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Director Allan R. Tessler 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Director Jay M. Moyes 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Director Fernando L. Fernandez 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Director Richard Krasno 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Director Richard C. Pfenniger 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Director David McClung 125 Shoreway Road San Carlos CA CALIFORNIA 94070 Executive Officer Biotechnology Decline to Disclose 06b false 2018-12-24 false true true false 0 4000000 4000000 0 false 3 200000 0 Fee paid as part of an exclusivity provision 0 false BioCardia, Inc. David McClung David McClung Chief Financial Officer 2019-01-07